FDA has approved new indicationsfor the UroLift System (NeoTract),a treatment for benign prostatichyperplasia that involves placement,via a minimally invasive procedure, ofpermanent implants that relieve prostaticobstruction and open the urethra. UroLift is now approved for use inmen with an obstructive median lobeand men as young as 45 years. Previously,UroLift was contraindicated inpatients with an obstructive medianlobe…
Most patients who discontinuehemodialysis (HD) prior to deathdo so with the aid of palliative careteams, researchers reported at the2018 Annual Dialysis Conference inOrlando, Florida. In a study of 262 adult patients whodiscontinued HD, Joy C.Y. Chen, MD,and colleagues at Mayo Clinic inRochester, Minnesota, found that 90 patients (34%) received palliative careconsultation within 6 months ofdeath…
Initial prostate size and percentagereduction in prostate volume predictoutcomes among men who undergoprostatic artery embolization (PAE) forbenign prostatic obstruction, researchersreported online in Cardiovascularand Interventional Radiation.The findings are from a prospectivefollow-up study of 86 men whounderwent PAE, of whom 62 (72.1%)had achieved clinical success at 12months. Investigators Drew Maclean,MBChB, and colleagues at UniversityHospital Southampton in Southampton,UK,…
Effective clinical trial design and ultimately drug approval require careful consideration of the endpoints selected.
Metabolic syndrome and smoking are associated with 2.5- and 1.7-fold increased odds of moderate or severe nocturia in men with BPH/LUTS.
Pregnant women with vs without a history of nephrolithiasis are more likely to experience gestational diabetes and preeclampsia.
Individuals who had a stroke or transient ischemic attack at age 60 to 64 had a 2-fold higher risk of UUI at age 68 years, a British study found.
Findings from a large study of men in the United Kingdom do not support single PSA testing for population-based screening.
Patients with end-stage renal disease (ESRD) due to autosomal polycystic kidney disease are more likely to receive a kidney transplant than those with ESRD from other causes, new study finds.
In a study, the 30-day readmission rate for hemodialysis patients hospitalized for cardiovascular events was 34.2%.
